CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP General Counsel & Secretary sold 1,715 shares at $11.46 ($19,655)
- 4 Open-market sale Director sold 995 shares at $11.46 ($11,403)
- 4/A Open-market sale Director sold 11,933 shares at an average $11.23 ($134,035)
- 4 Open-market buy CEO and President bought 1,000 shares at $11.57 ($11,567)
- 4 Open-market sale Director sold 11,933 shares at an average $11.23 ($134,035)
- 4 Open-market buy CEO and President bought 1,000 shares at $11.92 ($11,916)
- 4 Open-market buy CEO and President bought 1,000 shares at $11.34 ($11,336)
- 4 Shares withheld for taxes VP General Counsel & Secretary gave up 5,910 shares (to pay taxes)
- 4 Open-market buy Director bought 5,000 shares at $11.92 ($59,587)
- 4 Open-market buy SVP, CFO & Treasurer bought 1,000 shares at $13.22 ($13,220)
- 4 Open-market buy Director bought 5,000 shares at $13.18 ($65,900)
- 4 Open-market buy Director bought 5,000 shares at $13.88 ($69,400)
- 4 Open-market buy Director bought 5,000 shares at $14.73 ($73,650)
- 4 Open-market buy Director bought 5,000 shares at $14.70 ($73,500)
- 4 Open-market buy Director bought 5,000 shares at $14.85 ($74,250)
- 4 Open-market buy Director bought 5,000 shares at $13.84 ($69,200)
- 4 Open-market buy Director bought 5,000 shares at $12.94 ($64,700)
- 4 Open-market buy Director bought 5,000 shares at $11.91 ($59,550)
Page 17 of 19 · 378 filings